Fig. 3

The predicted endocrine disruption potential of four key metabolites: (I) Myricetin 3’-rhamnoside, (İ) Orientin 7-O-rhamnoside, (J) Protocatechuic acid, and (K) Prunasin.
The predicted endocrine disruption potential of four key metabolites: (I) Myricetin 3’-rhamnoside, (İ) Orientin 7-O-rhamnoside, (J) Protocatechuic acid, and (K) Prunasin.